Cochet C, Keramidas M, Souvignet C, Chambaz E M
Biochem Biophys Res Commun. 1986 Aug 14;138(3):1283-90. doi: 10.1016/s0006-291x(86)80422-3.
Potent tumor promoter TPA (1-100 nM) has previously been shown to induce a striking alteration of protein kinase C catalytic properties in target cells (C. Cochet et al., 1986, Biochem. Biophys. Res. Comm. 134, 1031-1037). This alteration contributes to the apparent loss of cellular protein kinase C, secondary to TPA treatment, when the enzyme is probed by its phospholipid-dependent histone kinase activity. This effect was observed as well when rat-1 cells were treated by other tumor promoters such as mezerein, teleocidin, aplysiatoxin and palytoxin, whereas inactive phorbol ester structures were ineffective. On the other hand, 1,2-dioctanoyl glycerol did not induce that effect. This protein kinase C alteration was shown to occur at the cellular membrane level. It is suggested that membrane translocation and activation of protein kinase C induced by potent tumor promoter structures are not functionally equivalent to that secondary to physiological stimuli. Although the mechanisms underlying this phenomenon remains to be understood at the molecular level, it may be of significance in the process of tumor promotion.
强效肿瘤促进剂佛波酯(TPA,1 - 100 nM)先前已被证明可诱导靶细胞中蛋白激酶C催化特性发生显著改变(C. 科谢等人,1986年,《生物化学与生物物理学研究通讯》134卷,1031 - 1037页)。当通过其磷脂依赖性组蛋白激酶活性检测该酶时,这种改变导致经TPA处理的细胞中蛋白激酶C明显丧失。当用其他肿瘤促进剂如芫花酯素、远侧霉素、海兔毒素和岩沙海葵毒素处理大鼠-1细胞时,也观察到了这种效应,而无活性的佛波酯结构则无效。另一方面,1,2 - 二辛酰甘油不会诱导这种效应。已证明这种蛋白激酶C的改变发生在细胞膜水平。有人提出,强效肿瘤促进剂结构诱导的蛋白激酶C的膜转位和激活在功能上与生理刺激诱导的情况不等同。尽管这一现象背后的分子机制仍有待了解,但它可能在肿瘤促进过程中具有重要意义。